ExThera Medical Announces Formation of New Business Advisory Board
April 23, 2024

Sam Shull

Experts Selected to Ensure Success of Paradigm Shifting Therapeutics

MARTINEZ, Calif. – ExThera Medical, a developer of oncologic and pathogen therapies, today announced the formation of an advisory board consisting of leading experts in business, government affairs/public policy, finance, and emerging technology.  The Business Advisory Board will work closely with ExThera’s executive team to advance the company’s metastatic oncology ONCOBindTM Procedure from development to commercialization.

“We are pleased to bring together a diversified group of accomplished professionals to support a new oncology therapy option for late-stage cancer patients that will revolutionize the space,” said Erin Borger, CEO of ExThera Medical.  “It’s an honor to have leading experts support us in our endeavors with their experience and insights.”

Business Advisory Board appointees are:

  • Admiral Bobby R. Inman (ret.)
  • Bill G. Lance, MPH, FACHE
  • Sherri J. Lance, MBA, MHR
  • The Honorable Scott Morrison, B.Sc. (Fmr. Australian Prime Minister)
  • Ambassador Robert C. O’Brien (ret.) 
  • Wm. Stuart Price, Esp.
  • Ambassador Joseph W. Westphal, PhD (ret.)

Bobby R. Inman, Adm. (ret.): Appointed tenured professor holding the Lyndon B. Johnson Centennial Chair in National Policy in August 2001 and adjunct professor since 1987 at the LBJ School of Public Affairs serving as Dean in 2005 and again from January 2009 to March 2010. Served in the U.S. Navy from November 1951 to July 1982, retiring with the permanent rank of admiral. On active duty he served as director of the National Security Agency and as deputy director of Central Intelligence. After retirement, chairman and CEO of the Microelectronics and Computer Technology Corporation (MCC) in Austin, Texas, and chairman, president, and chief executive officer of Westmark Systems Inc. Also served as chairman of the Federal Reserve Bank of Dallas from 1987 through 1990. Since 1990 has been investing in startup technology companies and is an elected fellow of the National Academy of Public Administration.

Bill G. Lance, Jr., MPH, FACHE: Secretary of State for the Chickasaw Nation, representing numerous civic, business, and governance capacities also serving prior as the Secretary of Commerce for more than thirteen years. Currently serving on the board of directors for several businesses owned by the Chickasaw Nation, including Sovereign Native Holdco, LLC (SNH) and related subsidiaries; and Chickasaw Nation Industries, Inc. (CNI). Bill serves as a Chickasaw Nation delegate on the Executive Committee of the American Gaming Association (AGA), National Indian Gaming Association (NIGA), Oklahoma Indian Gaming Association (OIGA), and the Inter-Tribal Council of the Five Civilized Tribes (ITC). He serves on BancFirst Board of Directors, the Chickasaw Foundation, and the OU Medicine Board of Directors. Bill also serves as a Non-Executive Director for Aristocrat Leisure. Bill has served as member of the Board of Trustees for the University of Oklahoma Foundation, the Oklahoma Department of Commerce Advisory Council, and as a regent for the University of Arts and Sciences of Oklahoma through June 2020. Also served as Administrator of the Chickasaw Nation Health System, where he oversaw the historic construction of a 370,000 square foot Chickasaw Nation Medical Center, located in Ada, Oklahoma.

Sherri J. Lance, MBA, MHR: Currently serving as President and Managing Partner at Gaming Capital Group, Sherri plays a pivotal role in shaping the strategic direction of the company while overseeing daily operations across multiple functions, including Marketing, Customer Relations, Legal, Compliance, IT, and HR. Under her leadership, Gaming Capital Group has become a trusted source of capital for the gaming industry, providing over $900 million in financing for casino and hotel projects since 2006. Held prior positions within the Chickasaw Nation Division of Commerce as Chief of Staff providing oversight for a wide range of departments, contributing to the success of revenue-generating ventures owned and operated by the Chickasaw Nation.  Deeply committed to community service, serving on the boards of various organizations, including the United Way of Central Oklahoma, the INTEGRIS Health System and the Oklahoma Association on Problem Gambling and Gaming. Her dedication to philanthropy and volunteerism is evident through her active involvement in initiatives aimed at improving the well-being of others.

Hon. Scott Morrison, B.Sc.: Served as Prime Minister of Australia from 2018 to 2022, successfully leading Australia through the global COVID 19 pandemic, achieving one of the world’s most effective public health and economic responses with the third lowest COVID fatality rate in the OECD while Australia’s economy outperformed all G7 and almost all OECD economies. As Prime Minister, was the architect and founder of the AUKUS trilateral defense agreement between Australia, the United Kingdom, and the United States, and founding member of the Quad leaders dialogue with India, Japan, and the United States. Completed numerous other diplomatic, trade and defense agreements, including the first ever bilateral defense forces reciprocal access agreement with Japan.  Domestically, stewarded the Australian economy to its lowest unemployment rate in almost 50 years, balancing the federal budget before the pandemic hit and returning it to a structural surplus, while ensuring Australia remained one of only nine countries in the world to maintain a AAA credit rating from all major international credit rating agencies. Prior services include acting as Cabinet Minister for five years, including three years as Federal Treasurer (2015-2018) as well as Minister for Immigration and Border Protection, where he designed and implemented Australia’s highly successful Operation Sovereign Borders policy. Additionally served on the National Security Committee for eight years and in the House of Representatives of Australia’s Commonwealth Parliament from 2007 to 2024. Now serves as non-executive Vice Chairman of US advisory firm, American Global Strategies as well as on several Strategic Advisory Boards in the private sector as well as the International Democracy Union, the Center for a New American Security and the Hudson Institute China Center.

Robert C. O’Brien: Served as the 27th United States National Security Advisor, the President’s principal advisor on all aspects of American foreign policy and national security affairs. Brought a renewed focus to defense and industrial base issues, orchestrated the historic Abraham Accords in the Middle East, brokered economic normalization between Serbia and Kosovo, and achieved increased cooperation with America’s allies across the Indo-Pacific. Previously, Robert was the Special Presidential Envoy for Hostage Affairs (SPEHA) and held the personal rank of ambassador, coordinating the government’s diplomatic engagements on overseas hostage-related matters. Additionally, Robert served as the U.S. Alternate Representative to the 60th session of the U.N. General Assembly and a member of the Cultural Property Advisory Committee. He was the founding co-chairman of the State Department’s Public-Private Partnership for Justice Reform in Afghanistan, serving under Secretaries of State Condoleezza Rice and Hillary Rodham Clinton. Robert was a senior legal officer at the U.N. Security Council in Geneva, Switzerland, and a Major in the U.S. Army Reserve JAG Corps. As a lawyer in the private sector, Robert co-founded and remains partner emeritus at Larson LLP, a national litigation boutique law firm with commercial litigation expertise handling class action, entertainment, intellectual property, environmental, business torts, and complex contractual matters in state and federal courts. Prior served as the California managing partner of a national Am Law 200 firm for nearly a decade and, earlier in his career, was an associate at Skadden, Arps, Slate, Meagher & Flom LLP.

Wm. Stuart Price, JD: Chairman of Price Family Properties that owns 50 percent of downtown Tulsa’s central business district as part of the commercial real estate portfolio that also manages 2.2 million square feet of commercial space, resulting in significant job creation and economic revitalization to the region. Prior professional experience includes a long tenure in the oil and gas industry. Service endeavors include appointment by former Governor Brad Henry to the Oklahoma State Regents for Higher Education where he volunteered 9 years to help better the 25 universities around the state. Also served on the Rogers State College Foundation and as Chair of the Tulsa Park and Recreation Board.  In 2007, helped create Tulsa Achieves, a gap funding program that provides tuition and financial assistance benefitting more than 20,000 Tulsa-area students, becoming a nationally recognized model of student success replicated throughout the US.

Joseph W. Westphal, Ph.D. (Ambassador): Global Senior Fellow at the Joseph H. Lauder Institute of Management and International Studies at The Wharton School of The University of Pennsylvania, Senior Fellow at the Center for Leadership and Change Management at Wharton, Fellow at the National Academy of Public Administration and Non-Resident Fellow at the International Studies Center of the Catholic University of Chile. Served as the U.S. Ambassador to the Kingdom of Saudi Arabia from March 2014 to January 2017, Under Secretary of the Army and its Chief Management Officer from 2009 to 2014, Acting Secretary of the Army in 2001, and lead on Force Management and the Army’s business operations as Assistant Secretary of the Army from 1998 to 2000.  In government, he worked in both the House and Senate for more than twelve years, worked as a staff member on the House Budget Committee and his last appointment was as a Special Assistant to Senator Thad Cochran (R-MS). He has held positions in the administrations of Presidents Carter, Reagan, Clinton, Bush, and Obama, working in the Department of the Interior, U.S. Army Corps of Engineers, the Environmental Protection Agency, the Department of Defense, and the Department of State. 

For more information, visit https://extheramedical.com/. 


About ExThera Medical Corporation
ExThera Medical Corporation develops and commercializes extracorporeal blood filtration devices, including the Seraph® 100 MicroBind® Affinity Blood Filter for removing a broad range of pathogens from the bloodstream of patients. Seraph can be used in hospitals, clinics, on battlefields and in other austere environments to address nosocomial and community-acquired infections as well as those caused by battlefield wounds, pandemics, and biological warfare agents. ExThera Medical’s extracorporeal products have demonstrated life-saving capabilities in a wide range of critically ill patients suffering from sepsis, COVID-19, and many other severe bloodstream infections. With a growing body of outcome and health economic evidence from independent clinical studies, success in the DARPA Dialysis-Like Therapeutics program, and from successful clinical use in the US, the EU, and the Middle East, the company is well positioned to serve healthcare professionals and patients alike. The Seraph 100 attained CE Mark and is commercially available in the EU under a broad Indication For Use. The Seraph 100 has FDA Emergency Use Authorization (EUA) for treatment of COVID-19 in the USA.

For more information, visit the company’s website at www.extheramedical.com.

About Seraph 100 and the ONCOBind Procedure
As a patient’s blood flows through the Seraph 100 filter, it passes through a bed of small beads with receptors that mimic the receptors on human cells that pathogens target when they invade the body. Many harmful substances are quickly captured and adsorbed onto the surface of the beads and are thereby subtracted from the bloodstream. Seraph adds nothing to the bloodstream. It targets the pathogens that cause the infection, while it also binds and removes harmful substances generated by the pathogen and by the body’s response to the infection. Seraph’s proprietary adsorption media (the beads) constitute a flexible platform that uses immobilized (chemically bonded) heparin for its well-established blood compatibility and its unique ability to bind circulating tumor cells, bacteria, viruses, fungi, and important sepsis mediators reported to contribute to organ failure during sepsis.

For more news stories on the Seraph 100 and the ONCOBind (cancer) Procedure, click here.

All information contained in this news release derives from plausible, reliable sources which, however, have not been independently examined. There is no warranty, confirmation or guarantee, and no responsibility or liability is taken concerning correctness or completeness. As far as it is allowed by the relevant law, no liability whatsoever is taken on for any direct or indirect loss caused by the deployment of this news release or its contents. This communication includes forward-looking statements regarding events, trends and business prospects that may affect our future operating results and financial position. Such statements are subject to risks and uncertainties that could cause our actual results and financial position to differ materially. The investment and/or the revenues that arise from it can rise or fall. A total loss is possible. Persons who are in possession of this news release are requested to obtain information concerning possible legal limitations and to observe them accordingly. We assume no responsibility to update or revise any forward-looking statements contained in this news release to reflect events, trends, or circumstances after the date of this news release. Results from case studies (reviews) may not be predictive of future results.


MM0031 Rev A